Funded Tech Companies
Sitryx Therapeutics
Sitryx Therapeutics is a leading biopharmaceutical tech venture, located in Oxford. Venture investment and financing was provided by Eli Lilly and Company, GlaxoSmithKline and Oxford Science Enterprises.
Company Overview
Company Name
Sitryx Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
101 Bellhouse Building Magdalen Centre The Oxford Science Pa
Oxford, OX4 4GA
UK
Oxford, OX4 4GA
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/27/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Weir
Chief Financial Officer
Jonathan Senior
Chief Marketing Officer
Ravi Ravo
Chief Scientific Officer
Iain Kilty
Company Investors
- Eli Lilly and Company
- GlaxoSmithKline
- Oxford Science Enterprises
- Sofinnova Partners
- Longwood Fund
- SV Health Investors
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs